Human African trypanosomiasis (HAT) or sleeping sickness, is a neglected disease that affects poor rural populations across sub-Saharan Africa. Confirmation of diagnosis is based on detection of parasites in either blood or lymph by microscopy. Here we present the development and the first phase evaluation of a simple and rapid test (HAT-PCR-OC) for detection of amplified Trypanosoma brucei DNA. PCR products are visualised on a dipstick through hybridisation with a gold conjugated probe (oligochromatography). Visualisation is straightforward and takes only 5 minutes. Controls for both the PCR reaction and for DNA migration are incorporated in the assay. The lower detection limit of the test is 5 fg of pure T.
Africa (23) . Over 60 million people are at risk of contracting the disease with an estimated 50-70,000 persons newly infected annually (2) . In the absence of treatment, HAT patients inevitably die after a more or less prolonged period of grave illness. Disease control for T. b.
gambiense relies heavily on accurate diagnosis and effective treatment of patients and for T.
b. rhodesiense on treatment of patients and of the animal reservoir (24) . Classical diagnosis requires demonstration of parasites in blood or lymph which for T. b. gambiense infection is problematic due to extremely low parasitaemias in infected people. It is estimated that 20 to 30% of the patients remain undiagnosed by standard parasitological techniques (20) . New molecular techniques based on the polymerase chain reaction (PCR) have been developed as surrogate for parasite detection. Applications of PCR for detecting T. brucei and its subspecies have been reported, which can be highly effective for detection of T. b.
rhodesiense and for distinguishing T. b. rhodesiense from T. b. gambiense (7, 16, 17, 18, 22, 25) . The use of these highly specific and sensitive PCR methods is however only suitable for screening for disease prevalence and for research purposes and are not commonly used to inform diagnosis of HAT (5) . This is partly due to the cumbersome methods of PCR product detection. Amplicons are normally identified using UV trans-illumination after being electrophoresed in the presence of ethidium bromide (a carcinogen). Alternative methods for Page 3 of 23 PCR product detection such as real-time PCR, PCR-ELISA or mass spectrometry have been developed (3, 10, 21) but are complex, expensive, equipment, recourse and personnel hungry. There is a demand for a simplified method of amplification and product detection which would make these tools useable in the facilities available in regional sleeping sickness diagnostic laboratories. (12, 13, 15, 19) . PCR products are visualised by hybridisation with a gold conjugated probe. This PCR product detection format takes only 5 minutes and no other equipment than a dry heating block and a pipette are needed. An internal control (IC) for the PCR reaction and a control for the chromatographic migration are incorporated in the assay.
We present here the development and phase I evaluation of a T. brucei specific PCROligochromatography test, called HAT-PCR-OC (Human African TrypanosomiasisPolymerase Chain Reaction-Oligochromatography). We have chosen the 18S ribosomal RNA gene (rDNA) as the target for the HAT-PCR-OC since it is a multi copy gene that contains sequences conserved within Trypanosomatids and species specific sequences (11).
Methods
Parasite DNA DNA was obtained from T. b. gambiense (LiTat 1.3) and T. b. rhodesiense (STIB 382) parasites amplified in HsdCpb:WU rats (Harlan, the Netherlands). Trypanosomes were separated from the blood using di-ethyl-amino-ethyl (DEAE) chromatography (9), followed by repeated centrifugation (20 
Non endemic controls
Venous blood on EDTA from 28 healthy human Belgian blood donors who had never visited a HAT endemic country (6) .
Endemic controls
Venous blood on EDTA from 50 healthy human volunteers in Kinshasa, D.R. Congo. 
Sleeping sickness patients

Spiked blood
Blood on EDTA spiked with T. b. gambiense (LiTat 1.3) parasites was used throughout the development of the assay and for the estimation of its lower detection limit. Bloodstream form trypanosomes were grown in rats. At day 3 post infection, tail blood was taken and diluted in PSG and the number of parasites per ml was counted in a KOVA cell counting chamber (Hycor Biomedical Inc., California, USA). A 10-fold dilution series of parasites was made in freshly taken naive human blood, ranging from 10,000 parasites/180 µl to 1 parasite/180 µl blood. Non-spiked blood was used as negative control.
DNA extraction from blood samples
As recommended by Qiagen, 180 µl of blood were mixed with an equal volume of AS1 buffer (Qiagen, Hilden, Germany) and stored at ambient temperature until DNA extraction.
Blood can be stored in this stabilising buffer for up to three months in the dark without loss of DNA quality. DNA was extracted with the QIAamp DNA mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions and stored at -20°C. Briefly, DNA is adsorbed onto the silica-gel membrane in the QIAamp Spin Column, washed by two centrifugation steps and eluted in 50 µl elution buffer. 180 µl sample of whole blood will yield an estimated 3 -12 µg of DNA. The internal control line in the oligochromatography (see below) showed the presence of inhibitory factors in the extracted DNA in some samples (1) . In such cases, DNA was further purified as follows: 1/10 volume of 3 M sodium acetate pH 5.2 and 2 volumes of ice-cold 100% ethanol were added, followed by overnight DNA precipitation at -20°C. The suspension was centrifuged at 16,100 g for 15 minutes and the Page 6 of 23 DNA resuspended in 500 µl of 70% ethanol. The suspension was again centrifuged for 10 minutes at 16,100 g and the ethanol was removed. DNA was dried in a vacuum chamber for at least 30 minutes and finally resuspended in 50 µl of water and stored at -20°C. donovani (GenBank accession number X07773) were aligned and primers (18S-F and 18S-R) were designed to amplify a sequence of the Trypanosomatidae 18S rDNA using the 'DNAman' software (Lynnon Corporation, Quebec, Canada). Primers are situated in Trypanosomatidae conserved sequences that surround a T. brucei conserved sequence. The reverse primer 18S-R was biotinylated at the 5' end.
T. brucei gold probe
The alignments described above were used to design a 17 bp DNA probe that can hybridise with a T. brucei specific sequence situated between the Trypanosomatidae conserved primer sequences. Absence of putative secondary structures within the expected PCR amplicon was checked via mfold version 3.1. (26) . The probe was conjugated with gold particles using the procedure described in Patent WO 2004/099438A1 (19) . 
Internal control DNA
IC gold probe
A DNA probe was designed that can hybridise with the 17 bp IC specific sequence within the IC DNA. This IC probe was conjugated with gold particles as described above.
Migration control probe
The migration control probe is identical to the 17 bp central sequence of the IC DNA.
PCR amplification
An asymmetric PCR was designed using 4 fold more biotinylated reverse primer than 
Preparation
The Oligochromatography (OC) dipstick is constructed with polymer backing faced on each side with a lower absorbent pad which overlaps a nitrocellulose membrane (in the middle) and an upper absorbent pad (Fig. 2) line. Both control lines determine whether the HAT-PCR-OC is valid or invalid (Fig. 3) . The migration control line should always be visible to validate the test. A test is invalid when both the IC amplicon control line and the T. brucei test line are invisible (Fig. 3d) indicating that the PCR reaction failed possibly due to inhibitory factors in the extracted DNA. When a sample contains very high concentrations of Trypanosomatidae DNA, competition between this target DNA and the IC template DNA for the primers can result in an invisible IC amplicon control line combined with a strongly visible T. brucei test line (Fig. 3c) . In the latter case, the test is considered valid. 
Results
Analytical sensitivity
The detection limit of the HAT-PCR-OC was evaluated on a serial dilution of T. b.
gambiense DNA in water. The lower detection limit was 5 fg of parasite DNA which is about 1/40 of the DNA content of one parasite (Fig. 4a) . Moreover, the test was able to detect ten times less DNA compared to agarose gel electrophoresis (data not shown). The lower detection limit was also evaluated on DNA extracted from a blood sample series spiked with decreasing numbers of living T. b. gambiense parasites. HAT-PCR-OC was consistently able to detect one single parasite in 180 µl of blood (Fig. 4b) . The assay remained negative when non-spiked control blood samples were tested.
Analytical specificity
The species specificity of the HAT-PCR-OC was assessed on purified DNA from T. b.
gambiense, T. b. rhodesiense, Leishmania donovani, Trypanosoma cruzi, Mycobacterium
Page 10 of 23 tuberculosis, Plasmodium falciparum and Schistosoma mansoni. Positive results were only obtained with the two T. brucei subspecies (Fig. 4c) . HAT-PCR-OC shows clear potential for implementation as a reference diagnostic test in mid level equipped laboratory facilities (clean laboratories with power and cold storage) and will be of particular value for evaluation of cure assessment during clinical trials of new drugs or drug combinations. The simple detection methodology described here may facilitate PCR application in HAT endemic countries. Further refinement of this assay will widen its application. New simple nucleic acid extraction techniques together with novel isothermal nucleic acid amplification methods such as loop-mediated isothermal amplification (LAMP) (8, 14) and nucleic acid based amplification (NASBA) (4) will mean that the constraint to field PCR (namely the need for thermocycling reactions) could be eliminated. 366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389 
